SALT LAKE CITY, May 08, 2018 (GLOBE NEWSWIRE) — Amedica Corporation (NASDAQ: AMDA), an innovative biomaterial company that develops and commercializes silicon nitride for biomedical applications, today provided an update on its clinical study activities. Single Center Retrospective Comparative Study A clinical study comparing silicon nitride spinal implants to allograft spacers in cervical fusion showed […]

Share on LinkedInShare on FacebookShare on Google+Pin on PinterestEmail this to someone